4. Industry Trends and Drivers
4.1 Increasing Pandemic Outbreak
4.2 Rising Affordability
4.3 Rising Ageing Population
4.4 Development of Universal Flu Vaccine
4.5 Collaborations in the Market
5. Industry Challenges
5.1 Testing and Regulatory Issues
5.2 Low Awareness
5.3 Lack of Medical and Healthcare Infrastructure
6. Global Influenza Vaccine Market Outlook 2022
6.1 Current Market Overview and Future Outlook
6.2 Major Marketed Vaccines
6.2.1 Fluzone/Vaxigrip
6.2.2 FluMist
6.2.3 Fluarix and Flulaval
6.2.4 Anflu
6.2.5 Fluvax/Afluria
6.2.6 Flucelvax and Fluvirin
7. Key Geographical Market
7.1 Americas
7.2 Europe
7.3 Asia Pacific
7.3.1 China
7.3.2 India
7.3.3 Australia
7.3.4 Japan
7.4 Rest of the World
8. Global Influenza Vaccine Market: Pipeline Analysis
9. Global Influenza Vaccine Market: Pricing Analysis
10. Competitive Assessment
10.1 Sanofi
10.1.1 Business Description
10.1.2 Financial Overview
10.1.3 Influenza Vaccine Business
10.2 GlaxoSmithKline Plc (GSK)
10.2.1 Business Overview
10.2.2 Financial Overview
10.2.3 Influenza Vaccine Business
10.3 CSL Ltd.
10.3.1 Business Overview
10.3.2 Financial Overview
10.3.3 Influenza Vaccine Business
10.4 AstraZeneca Plc
10.4.1 Business Overview
10.4.2 Financial Overview
10.4.3 Influenza Vaccine Business
10.5 Sinovac Biotech
10.5.1 Business Overview
10.5.2 Financial Overview
10.5.3 Influenza Vaccine Business